139 related articles for article (PubMed ID: 38599076)
1. A minimalist cancer cell membrane-shielded biomimetic nanoparticle for nasopharyngeal carcinoma active-targeting therapy.
Sun S; Han R; Sun Y; Chen W; Zhao L; Guan X; Zhang W
Colloids Surf B Biointerfaces; 2024 Jun; 238():113909. PubMed ID: 38599076
[TBL] [Abstract][Full Text] [Related]
2. Dual targetable drug delivery system based on cell membrane camouflaged liposome for enhanced tumor targeting and improved anti-tumor efficiency.
Duan M; Zhou D; Ke J; Chen Y; Wu W; Li Y; Ren J; Wang L; Zhang Z; Wang C
Colloids Surf B Biointerfaces; 2024 Jun; 238():113892. PubMed ID: 38581834
[TBL] [Abstract][Full Text] [Related]
3. A RBC membrane-camouflaged biomimetic nanoplatform for enhanced chemo-photothermal therapy of cervical cancer.
Luo L; Zeng F; Xie J; Fan J; Xiao S; Wang Z; Xie H; Liu B
J Mater Chem B; 2020 May; 8(18):4080-4092. PubMed ID: 32239064
[TBL] [Abstract][Full Text] [Related]
4. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
6. Curcumin loaded sub-30 nm targeting therapeutic lipid nanoparticles for synergistically blocking nasopharyngeal cancer growth and metastasis.
Luo H; Lu L; Liu N; Li Q; Yang X; Zhang Z
J Nanobiotechnology; 2021 Jul; 19(1):224. PubMed ID: 34320999
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
[TBL] [Abstract][Full Text] [Related]
8. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z
Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635
[TBL] [Abstract][Full Text] [Related]
9. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
[TBL] [Abstract][Full Text] [Related]
10. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
[TBL] [Abstract][Full Text] [Related]
11. A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy.
Xie W; Zhang Y; Xu Q; Zhong G; Lin J; He H; Du Q; Tan H; Chen M; Wu Z; Deng Y; Han Z; Lu J; Ye J; Zou F; Zhuo Y; Zhong W
Int J Nanomedicine; 2024; 19():3957-3972. PubMed ID: 38711614
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable Hollow Polydopamine@manganese Dioxide as an Oxygen Self-Supplied Nanoplatform for Boosting Chemo-photodynamic Cancer Therapy.
Wang H; Wang W; Liu L; Wang M; Li G; Li H; Li B; Yu S; Ma D; Xue W
ACS Appl Mater Interfaces; 2021 Dec; 13(48):57009-57022. PubMed ID: 34806877
[TBL] [Abstract][Full Text] [Related]
13. A Biomimetic Gold Nanocages-Based Nanoplatform for Efficient Tumor Ablation and Reduced Inflammation.
Xu Q; Wan J; Bie N; Song X; Yang X; Yong T; Zhao Y; Yang X; Gan L
Theranostics; 2018; 8(19):5362-5378. PubMed ID: 30555552
[TBL] [Abstract][Full Text] [Related]
14. Cancer Cell-Membrane Biomimetic Boron Nitride Nanospheres for Targeted Cancer Therapy.
Feng S; Ren Y; Li H; Tang Y; Yan J; Shen Z; Zhang H; Chen F
Int J Nanomedicine; 2021; 16():2123-2136. PubMed ID: 33731994
[TBL] [Abstract][Full Text] [Related]
15. Bioinspired Virus-like Fe
Zhao L; Song X; Ouyang X; Zhou J; Li J; Deng D
ACS Appl Mater Interfaces; 2021 Oct; 13(42):49631-49641. PubMed ID: 34636534
[TBL] [Abstract][Full Text] [Related]
16. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy.
Wu G; Wang Z; Bian X; Du X; Wei C
Pharm Biol; 2014 Aug; 52(8):978-82. PubMed ID: 25017652
[TBL] [Abstract][Full Text] [Related]
17. Acid-Activated TAT Peptide-Modified Biomimetic Boron Nitride Nanoparticles for Enhanced Targeted Codelivery of Doxorubicin and Indocyanine Green: A Synergistic Cancer Photothermal and Chemotherapeutic Approach.
Li H; Fan Y; Shen Y; Xu H; Zhang H; Chen F; Feng S
ACS Appl Mater Interfaces; 2024 May; 16(19):25101-25112. PubMed ID: 38691046
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy.
Gong C; Yu X; You B; Wu Y; Wang R; Han L; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2020 Jun; 18(1):92. PubMed ID: 32546174
[TBL] [Abstract][Full Text] [Related]
19. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
[TBL] [Abstract][Full Text] [Related]
20. A robust pH-sensitive unimolecular dendritic nanocarrier that enables targeted anti-cancer drug delivery via GLUT transporters.
Kumar P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2018 Nov; 171():437-444. PubMed ID: 30075419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
